Investor relations is an increasingly common escape route for both equity researchers seeking a new path, and M&A bankers looking for a change. But switching out of investment banking doesn’t mean that you’re cast into a career hinterland, never to return.
Case in point is Maren Winnick. She left her job as a vice president in M&A shareholder advisory at Goldman Sachs in March last year to head up corporate finance and investor relations at biotech firm Moderna Therapeutics in March last year.
She has just joined Evercore as a managing director within its investment bank in New York.
The boutique investment bank has been hiring over the past six months and, of all the small players gaining ground on the bulge brackets, has made the most ground. Evercore was 10th in the Q1 global M&A league tables with $42.5bn worth of deals, according to Dealogic, up from 25th at the same point last year. This is primarily due to gains in the U.S – in Q117 Evercore was 9th by deal volume in North America, up from 25th in Q1 2016.
Winnick spent eight years at Goldman Sachs in both M&A and equity capital markets roles, having joined in 2008 after an MBA from Columbia Business School.
She’s not the only Goldmanite to leave the bank for a senior role at smaller firm in recent months. Matthew Borsch, its lead analyst for the healthcare services sector, has just joined BMO Capital Markets as a managing director and senior research analyst for healthcare.
Borsch joined Goldman in February 2001 after four years working as a director of business development at healthcare firm Telesis Medical Management.
Image: Getty Images